 SOUTH SAN FRANCISCO, Calif. , Nov. 1, 2022 PRNewswire -- IDEAYA Biosciences, Inc. NASDAQ: IDYA, a synthetic lethality focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in investor conferences in November 2022 and its plans to host an Investor RD Day in December 2022. 